Difference between revisions of "Giant Jamboree/Schedule/Sunday"

Line 42: Line 42:
  
 
<div class="column quarter_size">
 
<div class="column quarter_size">
<img src="https://www.pvpbio.com/wp-content/uploads/2017/03/Ingrid-1.jpg">
+
<h4> iGEM Experience </h4>
 +
<ul>
 +
 
 +
<li>iGEM 2008-2011
 +
<li>Led the 2011 Grand Prize Winner, Washington
 +
<li>Founded PVP Bio with the team project from 2011
 +
<li>PVP Bio got $35 million investment from Takeda Pharmaceuticals
 +
</ul>
 
</div>
 
</div>
  
Line 48: Line 55:
  
 
<h3>Ingrid Swanson Pultz</h3>
 
<h3>Ingrid Swanson Pultz</h3>
 +
<h4> CSO of PVP Bio</h4>
 
<p>
 
<p>
 
Ingrid Swanson Pultz, Ph.D., is a co-founder and the chief scientific officer of PvP Biologics. Dr. Pultz is a leader in computational enzyme design, and has a distinguished track record of leading research teams to success. As an inventor of PvP’s gluten-degrading enzyme technology and an entrepreneur, Dr. Pultz has established cross-disciplinary connections and bridged industry with academia to accomplish research goals. Dr. Pultz established PvP Biologics in 2012 and joined the team as its chief scientific officer in 2016. Prior to PvP Biologics, Dr. Pultz led the effort to develop effective therapeutics for celiac disease at the Institute for Protein Design at the University of Washington, where she held a faculty position in the Department of Biochemistry. Dr. Pultz completed her Ph.D. in microbiology at Washington in the laboratory of Dr. Samuel Miller, and post-doctoral research with Dr. David Baker. She holds a B.A. in biology from Wellesley College. While operating at the forefront of protein engineering, Dr. Pultz also has a strong interest in training the next generation of effective leaders in science and technology. Dr. Pultz has received numerous awards and recognitions including a Life Sciences Discovery Fund grant, the Neil Groman Award for Excellence in Teaching, and a competitive NSF research fellowship.
 
Ingrid Swanson Pultz, Ph.D., is a co-founder and the chief scientific officer of PvP Biologics. Dr. Pultz is a leader in computational enzyme design, and has a distinguished track record of leading research teams to success. As an inventor of PvP’s gluten-degrading enzyme technology and an entrepreneur, Dr. Pultz has established cross-disciplinary connections and bridged industry with academia to accomplish research goals. Dr. Pultz established PvP Biologics in 2012 and joined the team as its chief scientific officer in 2016. Prior to PvP Biologics, Dr. Pultz led the effort to develop effective therapeutics for celiac disease at the Institute for Protein Design at the University of Washington, where she held a faculty position in the Department of Biochemistry. Dr. Pultz completed her Ph.D. in microbiology at Washington in the laboratory of Dr. Samuel Miller, and post-doctoral research with Dr. David Baker. She holds a B.A. in biology from Wellesley College. While operating at the forefront of protein engineering, Dr. Pultz also has a strong interest in training the next generation of effective leaders in science and technology. Dr. Pultz has received numerous awards and recognitions including a Life Sciences Discovery Fund grant, the Neil Groman Award for Excellence in Teaching, and a competitive NSF research fellowship.

Revision as of 18:13, 16 August 2018

Loading...

SUNDAY SCHEDULE

iGEM Experience

  • iGEM 2008-2011
  • Led the 2011 Grand Prize Winner, Washington
  • Founded PVP Bio with the team project from 2011
  • PVP Bio got $35 million investment from Takeda Pharmaceuticals

Ingrid Swanson Pultz

CSO of PVP Bio

Ingrid Swanson Pultz, Ph.D., is a co-founder and the chief scientific officer of PvP Biologics. Dr. Pultz is a leader in computational enzyme design, and has a distinguished track record of leading research teams to success. As an inventor of PvP’s gluten-degrading enzyme technology and an entrepreneur, Dr. Pultz has established cross-disciplinary connections and bridged industry with academia to accomplish research goals. Dr. Pultz established PvP Biologics in 2012 and joined the team as its chief scientific officer in 2016. Prior to PvP Biologics, Dr. Pultz led the effort to develop effective therapeutics for celiac disease at the Institute for Protein Design at the University of Washington, where she held a faculty position in the Department of Biochemistry. Dr. Pultz completed her Ph.D. in microbiology at Washington in the laboratory of Dr. Samuel Miller, and post-doctoral research with Dr. David Baker. She holds a B.A. in biology from Wellesley College. While operating at the forefront of protein engineering, Dr. Pultz also has a strong interest in training the next generation of effective leaders in science and technology. Dr. Pultz has received numerous awards and recognitions including a Life Sciences Discovery Fund grant, the Neil Groman Award for Excellence in Teaching, and a competitive NSF research fellowship.